Levetiracetam use in critically ill patients

By Szaflarski Jerzy   Meckler Jason   Szaflarski Magdalena   Shutter Lori   Privitera Michael   Yates Stephen  

Neurocritical Care, Vol. 7, Iss. 2, 2007-10 ,pp. : 140-147

Humana Press, Inc

Access to resources Recommend Favorite

Safety and Efficacy of Molgramostim as an Adjunctive Therapy in Critically Ill Patients with Severe Sepsis

By Myrianthefs Pavlos M.   Karabatsos Elias G.   Karatzas Stylianos P.   Boutzouka Eleni G.   Venetsanou Kyriaki F.   Evagelopoulou Penelope L.   Fildissis George A.   Legakis Nicolaos J.   Baltopoulos George J.  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 3, 2003-01 ,pp. : 175-179

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1048-1057

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clopidogrel in Critically Ill Patients

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 217-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial‐onset seizures

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 10, 2015-10 ,pp. : 640-648

John Wiley & Sons Inc

Access to resources Recommend Favorite